Clinical Trial Update: Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pentostatin and rituximab, with or without cyclophosphamide, in previously untreated chronic lymphocytic leukemia (B-CLL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Pentostatin (pentostatin)
• Rituximab (rituximab)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: B-Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED